ARCHIVES

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

This article is from The Cancer Letter archive.

Vol. 33 No. 02 | January 19, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Gets Out of the News Business

January 25, 2013

Sirolimus-Containing Therapy Reduces GVHD, Study Finds

January 31, 2003

Nebraska Legislature Revives Eppley With New Cigarette Tax

June 25, 1981

Ax Falls; Recision Asked Of $17 Million For NCI This Year, $42.7 Million Cut In FY 1981 Budget

April 4, 1980

NCI Director May Alert Cancer Panel to Freeze On GS-13 Promotion

November 4, 1994

Promotions at MSKCC: Fuks heads radiation oncology, Pfister named chief of Head & Neck Medical Oncology Service.

October 15, 2004